270 related articles for article (PubMed ID: 31866618)
1. Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016.
Kawano N; Nagahiro Y; Yoshida S; Tahara Y; Himeji D; Kuriyama T; Tochigi T; Nakaike T; Shimokawa T; Yamashita K; Ochiai H; Marutsuka K; Mashiba K; Shimoda K; Teshima T; Kikuchi I
J Clin Exp Hematop; 2019; 59(4):156-167. PubMed ID: 31866618
[TBL] [Abstract][Full Text] [Related]
2. A case series of adult T-cell leukemia-lymphoma, associated with human T-cell leukemia virus type-1, at a single center in a non-viral-endemic metropolitan area.
Akuzawa Y; Tsukasaki K; Saeki T; Okamura D; Ishikawa M; Maeda T; Kohri M; Takahashi N; Matsuda A; Kawai N; Asou N
J Clin Exp Hematop; 2019; 59(3):108-111. PubMed ID: 31564712
[TBL] [Abstract][Full Text] [Related]
3. Adult T-cell leukemia-lymphoma.
Tsukasaki K
Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
[TBL] [Abstract][Full Text] [Related]
5. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.
Yamaguchi K; Watanabe T
Int J Hematol; 2002 Aug; 76 Suppl 2():240-5. PubMed ID: 12430931
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population.
Ikeda S; Momita S; Kinoshita K; Kamihira S; Moriuchi Y; Tsukasaki K; Ito M; Kanda T; Moriuchi R; Nakamura T
Blood; 1993 Oct; 82(7):2017-24. PubMed ID: 8400254
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
Sakihama S; Saito M; Kuba-Miyara M; Tomoyose T; Taira N; Miyagi T; Hayashi M; Kinjo S; Nakachi S; Tedokon I; Nishi Y; Tamaki K; Morichika K; Uchihara JN; Morishima S; Karube KN; Tanaka Y; Masuzaki H; Fukushima T
Leuk Res; 2017 Oct; 61():18-24. PubMed ID: 28866351
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
9. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
[TBL] [Abstract][Full Text] [Related]
11. [Composite adult T-cell leukemia/lymphoma and Epstein-Barr virus-positive diffuse large B-cell lymphoma].
Sakamoto H; Imaizumi Y; Niino D; Takeuchi M; Matsui K; Horai M; Sato S; Akazawa Y; Ando K; Sawayama Y; Hata T; Ohshima K; Miyazaki Y
Rinsho Ketsueki; 2020; 61(4):305-311. PubMed ID: 32378571
[TBL] [Abstract][Full Text] [Related]
12. Immunological studies on opportunistic infection and the development of adult T-cell leukemia.
Tashiro T; Yamasaki T; Nagai H; Kikuchi H; Nasu M
Intern Med; 1992 Sep; 31(9):1132-6. PubMed ID: 1421724
[TBL] [Abstract][Full Text] [Related]
13. Adult T cell leukaemia-lymphoma.
Yamaguchi K; Takatsuki K
Baillieres Clin Haematol; 1993 Dec; 6(4):899-915. PubMed ID: 8038496
[TBL] [Abstract][Full Text] [Related]
14. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country.
Valcarcel B; Enriquez-Vera D; De-la-Cruz-Ku G; Chambergo-Michilot D; Calderón-Huaycochea H; Malpica L
JCO Glob Oncol; 2023 Mar; 9():e2200369. PubMed ID: 36921240
[TBL] [Abstract][Full Text] [Related]
16. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
Takemoto S; Iwanaga M; Sagara Y; Watanabe T
Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
[TBL] [Abstract][Full Text] [Related]
18. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
[TBL] [Abstract][Full Text] [Related]
19. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
[TBL] [Abstract][Full Text] [Related]
20. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
Cook LB; Taylor GP
Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
